1. Home
  2. LSTA vs ACCL Comparison

LSTA vs ACCL Comparison

Compare LSTA & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.54

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$2.98

Market Cap

26.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
LSTA
ACCL
Founded
1980
2009
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.9M
26.9M
IPO Year
2000
2024

Fundamental Metrics

Financial Performance
Metric
LSTA
ACCL
Price
$1.54
$2.98
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
551.1K
44.6K
Earning Date
05-11-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
20.42
N/A
EPS
N/A
N/A
Revenue
$35,283,868.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.13
Revenue Growth
56.90
N/A
52 Week Low
$0.99
$1.23
52 Week High
$5.07
$5.00

Technical Indicators

Market Signals
Indicator
LSTA
ACCL
Relative Strength Index (RSI) 46.30 56.09
Support Level $1.23 $2.80
Resistance Level $2.11 $3.20
Average True Range (ATR) 0.23 0.20
MACD 0.04 -0.03
Stochastic Oscillator 42.61 74.62

Price Performance

Historical Comparison
LSTA
ACCL

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: